340B Drug Pricing Program
340B ADR process goes live June 18; informational webinar being held June 11The new 340B Administrative Dispute Resolution process, finalized by the Department of Health and Human Services April 18, goes into effect June 18. HRSA’s Office of Pharmacy Affairs June 11 will host a webinar to provide…
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent a letter to the subcommittee for the hearing, urging Congress to protect the program and highlighted its value to hospitals and health…
The House Energy and Commerce Oversight and Investigations subcommittee today hosted a hearing to discuss oversight of the 340B Drug Pricing Program.
AHA expresses strong support for the 340B program and urges Congress to protect this critical program as it has done for more than three decades.
AHA 340B Advocacy Alliance Bulletin for May 30, 2024.
The House Energy and Commerce Committee Subcommittee on Oversight and Investigations (O…
AHA 340B Advocacy Alliance Bulletin for May 21,2024.
The Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) April 19 published the 340B Administrative Dispute Resolution (ADR) final rule establishing a process that was required under the Affordable Care Act.
The Department of Health and Human Services April 18 finalized its rule to establish a 340B Administrative Dispute Resolution process as required under the Affordable Care Act.
The Administration’s final rule for the 340B drug pricing program administrative dispute resolution (ADR) process is an important step in ensuring the integrity of the 340B program. The final rule contains several important process improvements, including a clear timeline for when ADR decisions…